alNeedsinIVD8.1.3GreatestObstaclestoMarketGrowth8.1.4ProspectsforIVDMarketGrowthinDevelopingCountries8.1.5ProspectsforTheranostics8.2InterviewwithHerbieNewell,ProfessorofCancerTherapeutics,NorthernInstituteforCancerResearch,UniversityofNewcastle,UK8.2.1TheImportanceofBiomarkersforCancerTherapy8.2.2TechnologicalPlatformsUsedintheDiscoveryofNovelBiomarkers8.2.3TheChallengesofTranslatingCancerBiomarkerDiscoveriestotheClinic8.2.4CancerHeterogeneityandTargetedTherapy8.2.5ReforminPharmaceuticalR&DandtheImportanceofPublic-PrivatePartnerships8.2.6CurrentTrendsandtheFutureofCancerResearch8.3VicePresident,pany(ViewsProvidedAnonymously)8.3.panionDiagnostics8.3.panionDiagnosticsMarket8.3.panionDiagnosticsMarket8.3.panionDiagnosticTests8.3.panionDiagnosticsMarketandFutureGrowth8.4Chineseexpertopinion10